Key Metrics of Marriott International
Revenue$23.7B▲ 14.2% YoYFY 2023
Operating income$3.9B▲ 11.6% YoY
Net profit$3.1B▲ 30.7% YoY
Shareholders' equity−$682M
Market cap$102BMAR · $390.71
Competitors10identified
About Marriott International
Sectors
Company details
- Website
- marriott.com.cn
- Listed
- Nasdaq: MAR
Operational Areas of Marriott International
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameMarriott International
TickerMAR
ExchangeNasdaq
CountryUnited States
SEC CIK0001048286
Listed since—
IndustryHotels/Resorts
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://www.marriott.com.cn
US market & SEC filings
MAR · Nasdaq · SEC CIK 0001048286
Last price · 27 Oct 2026
$390.71
−1.54%
Market cap$102B
P/E38.4On FY 2023 diluted EPS
Volume1,356,746
SectorConsumer DiscretionaryHotels/Resorts
Country · IPOUnited States
MAR share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeBethesda
GSTIN—
Email—
Websitehttps://www.marriott.com.cn
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Marriott International
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Similar companies
D
Dhanuka Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
E
ENTERO HEALTHCARE SOLUTIONS LIMITEDPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
M
METROPOLIS HEALTHCARE LIMITEDPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
N
Nectar Lifesciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
T
Themis Medicare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
S
Sakar Healthcare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
I
IOL Chemicals and Pharmaceuticals Ltd. (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
Poly Medicure (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
AC HOTELS PRIVATE LIMITEDTradingBusiness activities and related parties
hospitality industry, tourism industry
Filings
No filings on record yet.